RAPT Therapeutics, Inc.
RAPT
$0.7479
-$0.1309-14.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -116.51M | -129.87M | -107.49M | -120.43M | -118.05M |
| Total Depreciation and Amortization | 1.14M | 1.20M | 1.24M | 1.27M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.00M | 19.46M | 18.60M | 17.36M | 14.80M |
| Change in Net Operating Assets | -12.26M | 25.91M | -12.97M | -3.07M | -3.51M |
| Cash from Operations | -108.63M | -83.30M | -100.61M | -104.88M | -105.53M |
| Capital Expenditure | -60.00K | -122.00K | -188.00K | -237.00K | -471.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.19M | 52.82M | 74.37M | 81.73M | 95.18M |
| Cash from Investing | -20.25M | 52.70M | 74.18M | 81.49M | 94.71M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 143.82M | 152.85M | 10.20M | 10.30M | 10.37M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 143.82M | 152.85M | 10.20M | 10.30M | 10.37M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.94M | 122.26M | -16.24M | -13.09M | -451.00K |